The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

An FDA advisory panel vote of 9-1 to recommend the approval of Mesoblast Limited’s graft versus host disease (GVHD) cell therapy was a cruel tease for the Australian company. More than four ...

But let's have a look. The now-approved treatment for acute GVHD is indicated for patients 2 months of age and up after developing steroid-refractory disease. This was based on high response rates ...

A transplant using your own stem cells is called an autograft or autologous transplant. GvHD is a possible complication of a transplant from another person. GvHD means the graft reacts against the ...

Considering taking supplements to treat graft versus host disease gvhd? Below is a list of common natural remedies used to treat or reduce the symptoms of graft versus host disease gvhd.

The therapy, branded as Ryoncil, is the first mesenchymal stromal cell therapy approved to treat pediatric patients aged two months and older whose GVHD symptoms have not responded to standard ...